Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances

Medical Hypotheses

Volumn 74, Issue 5, 2010, Pages 928-933

  Brower, Kirk J ^a   Perron, Brian E ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; HYPNOTIC SEDATIVE AGENT; PSYCHOTROPIC AGENT;

ALCOHOLISM; ARTICLE; COCAINE DEPENDENCE; CONCEPTUAL FRAMEWORK; DISEASE ASSOCIATION; DRUG DEPENDENCE; EVIDENCE BASED MEDICINE; HUMAN; NEUROBIOLOGY; OPIATE ADDICTION; POLYSOMNOGRAPHY; PSYCHOSOCIAL ENVIRONMENT; PUBLIC HEALTH; RECURRENCE RISK; RELAPSE; RISK FACTOR; SLEEP DISORDER; SOCIAL PSYCHOLOGY; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

HUMANS; MODELS, BIOLOGICAL; PSYCHOTROPIC DRUGS; RECURRENCE; RISK FACTORS; SLEEP DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 77950946918     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.10.020     Document Type: Article

References (95)

1. Bauer L.O., Covault J., Harel O., et al. Variation in GABRA2 predicts drinking behavior in project MATCH subjects. Alcohol Clin Exp Res 2007, 31:1780-1787.
2. Finckh U., Rommelspacher H., Kuhn S., et al. Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics 1997, 7:271-281.
3. Florez G., Saiz P., Garcia-Portilla P., et al. Association between the Stin2 VNTR polymorphism of the serotonin transporter gene and treatment outcome in alcohol-dependent patients. Alcohol Alcohol 2008, 43:516-522.
4. Pinto E., Reggers J., Gorwood P., et al. The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence. Alcohol Alcohol 2008, 43:398-400.
5. Wojnar M., Brower K.J., Strobbe S., et al. Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence. Alcohol Clin Exp Res 2009, 33:693-702.
6. Wrase J., Makris N., Braus D.F., et al. Amygdala volume associated with alcohol abuse relapse and craving. Am J Psychiatry 2008, 165:1179-1184.
7. Adinoff B., Junghanns K., Kiefer F., Krishnan-Sarin S. Suppression of the HPA axis stress-response: implications for relapse. Alcohol Clin Exp Res 2005, 29:1351-1355.
8. Heinz A., Dettling M., Kuhn S., et al. Blunted growth hormone response is associated with early relapse in alcohol-dependent patients. Alcohol Clin Exp Res 1995, 19:62-65.
9. George D.T., Rawlings R., Eckardt M.J., Phillips M.J., Shoaf S.E., Linnoila M. Buspirone treatment of alcoholism: age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking. Alcohol Clin Exp Res 1999, 23:272-278.
10. 123I] iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients. Am J Psychiatry 2000, 157:127-129.
11. Heinz A., Lichtenberg-Kraag B., Baum S.S., et al. Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome. J Neural Transm Gen Sect 1995, 102:149-157.
12. Junghanns K., Backhaus J., Tietz U., et al. Impaired serum cortisol stress response is a predictor of early relapse. Alcohol Alcohol 2003, 38:189-193.
13. Kiefer F., Jahn H., Otte C., Demiralay C., Wolf K., Wiedemann K. Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism. J Psychiatr Res 2005, 39:545-551.
14. Kiefer F., Jahn H., Otte C., Naber D., Wiedemann K. Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?. Biol Psychiatry 2006, 60:74-76.
15. Markianos M., Lykouras L., Moussas G., Hatzimanolis J. Changes in dopamine receptor responsivity during alcohol detoxification may predict relapse. Drug Alcohol Depend 2001, 64:363-365.
16. Rasmusson A.M., Wu R., Paliwal P., Anderson G.M., Krishnan-Sarin S. A decrease in the plasma DHEA to cortisol ratio during smoking abstinence may predict relapse: a preliminary study. Psychopharmacology (Berl) 2006, 186:473-480.
17. Schmidt L.G., Dettling M., Graef K.J., et al. Reduced dopaminergic function in alcoholics is related to severe dependence. Biol Psychiatry 1996, 39:193-198.
18. Grusser S.M., Wrase J., Klein S., et al. Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology 2004, 175:296-302.
19. Heinz A., Wrase J., Kahnt T., et al. Brain activation elicited by affectively positive stimuli is associated with a lower risk of relapse in detoxified alcoholic subjects. Alcohol Clin Exp Res 2007, 31:1138-1147.
20. Paulus M.P., Tapert S.F., Schuckit M.A. Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry 2005, 62:761-768.
21. Bauer L.O. Electroencephalographic and autonomic predictors of relapse in alcohol-dependent patients. Alcohol Clin Exp Res 1994, 18(3):755-760.
22. Bauer L.O. Frontal P300 decrements, childhood conduct disorder, family history, and the prediction of relapse among abstinent cocaine abusers. Drug Alcohol Depend 1997, 44:1-10.
23. Bauer L.O. Predicting relapse to alcohol and drug abuse via quantitative electroencephalography. Neuropsychopharmacology 2001, 25:332-340.
24. Glenn S.W., Sinha R., Parsons O.A. Electrophysiological indices predict resumption of drinking in sober alcoholics. Alcohol 1993, 10:89-95.
25. Saletu-Zyhlarz G.M., Arnold O., Anderer P., et al. Differences in brain function between relapsing and abstaining alcohol-dependent patients, evaluated by EEG mapping. Alcohol Alcohol 2004, 39:233-240.
26. Winterer G., Kloppel B., Heinz A., et al. Quantitative EEG (QEEG) predicts relapse in patients with chronic alcoholism and points to a frontally pronounced cerebral disturbance. Psychiatry Res 1998, 78(1-2):101-113.
27. Brower K.J., Aldrich M.S., Hall J.M. Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcohol Clin Exp Res 1998, 22:1864-1871.
28. Drummond S.P.A., Gillin J.C., Smith T.L., DeModena A. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res 1998, 22:1796-1802.
29. Gillin J.C., Smith T.L., Irwin M., Butters N., Demodena A., Schuckit M. Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in nondepressed patients with primary alcoholism at 3-month follow-up. Arch Gen Psychiatry 1994, 51:189-197.
30. Kalivas P.W., O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008, 33:166-180.
31. Heinz A., Beck A., Grusser S.M., Grace A.A., Wrase J. Identifying the neural circuitry of alcohol craving and relapse vulnerability. Addict Biol 2009, 14:108-118.
32. Koob G.F. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56(Suppl. 1):18-31.
33. Goldstein R.Z., Craig A.D., Bechara A., et al. The neurocircuitry of impaired insight in drug addiction. Trends Cogn Sci 2009, 13:372-380.
34. American Psychiatric Association. DSM-IV-TR: diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington, DC: American Psychiatric Association; 2000.
35. Arnedt J.T., Conroy D.A., Brower K.J. Treatment options for sleep disturbances during alcohol recovery. J Addict Dis 2007, 26:41-54.
36. Conroy D.A., Todd Arnedt J., Brower K.J. Insomnia in patients with addictions: a safer way to break the cycle. Curr Psychiatry 2007, 7(5):97-110.
37. Brower K.J. Alcohol's effects on sleep in alcoholics. Alcohol Res Health 2001, 25:110-125.
38. Brower K.J. Insomnia, alcoholism and relapse. Sleep Med Rev 2003, 7:523-539.
39. Conroy D.A., Todd Arnedt J., Brower K.J., et al. Perception of sleep in recovering alcohol-dependent patients with insomnia: relationship with future drinking. Alcohol Clin Exp Res 2006, 30:1992-1999.
40. Feige B., Scaal S., Hornyak M., Gann H., Riemann D. Sleep electroencephalographic spectral power after withdrawal from alcohol in alcohol-dependent patients. Alcohol Clin Exp Res 2007, 31:19-27.
41. Malcolm R., Myrick L.H., Veatch L.M., Boyle E., Randall P.K. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs. gabapentin. J Clin Sleep Med 2007, 3:24-32.
42. Choi S.Y. Dreams as a prognostic factor in alcoholism. Am J Psychiatry 1973, 130:699-702.
43. Christo G., Franey C. Addicts' drug-related dreams: their frequency and relationship to six-month outcomes. Subst Use Misuse 1996, 31:1-15.
44. Flowers L.K., Zweben J.E. The changing role of " using" dreams in addiction recovery. J Subst Abuse Treat 1998, 15:193-200.
45. Sofuoglu M., Dudish-Poulsen S., Poling J., Mooney M., Hatsukami D.K. The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users. Addict Behav 2005, 30:1125-1134.
46. Gann H., Feige B., Hohagen F., van Calker D., Geiss D., Dieter R. Sleep and the cholinergic rapid eye movement sleep induction test in patients with primary alcohol dependence. Biol Psychiatry 2001, 50:383-390.
47. Boutou A.K., Tsiata E.A., Pataka A., Kontou P.K., Pitsiou G.G., Argyropoulou P. Smoking cessation in clinical practice: predictors of six-month continuous abstinence in a sample of Greek smokers. Primary Care Respir J 2008, 17:32-38.
48. Foulds J., Gandhi K.K., Steinberg M.B., et al. Factors associated with quitting smoking at a tobacco dependence treatment clinic. Am J Health Behav 2006, 30:400-412.
49. Scharf D.M., Dunbar M.S., Shiffman S. Smoking during the night: prevalence and smoker characteristics. Nicotine Tob Res 2008, 10:167-178.
50. Dijkstra B.A., De Jong C.A., Krabbe P.F., van der Staak C.P. Prediction of abstinence in opioid-dependent patients. J Addict Med 2008, 2:194-201.
51. Becker W.C., Fiellin D.A., Desai R.A. Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlates. Drug Alcohol Depend 2007, 90:280-287.
52. Carter L.P., Griffiths R.R., Suess P.E., Casada J.H., Wallace C.L., Roache J.D. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects. J Pharmacol Exp Ther 2007, 322:749-759.
53. Victorri-Vigneau C., Dailly E., Veyrac G., Jolliet P. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 2007, 64:198-209.
54. Griffiths R.R., Johnson M.W. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry 2005, 66(Suppl. 9):31-41.
55. West R., Gossop M. Overview: a comparison of withdrawal symptoms from different drug classes. Addiction 1994, 89:1483-1489.
56. Aston-Jones G., Harris G.C. Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 2004, 47(Suppl. 1):167-179.
57. Martinotti G., Nicola M.D., Reina D., et al. Alcohol protracted withdrawal syndrome: the role of anhedonia. Subst Use Misuse 2008, 43:271-284.
58. Hornyak M., Haas P., Veit J., Gann H., Riemann D. Magnesium treatment of primary alcohol-dependent patients during subacute withdrawal: an open pilot study with polysomnography. Alcohol Clin Exp Res 2004, 28:1702-1709.
59. Wong M.M., Brower K.J., Zucker R.A. Childhood sleep problems, early onset of substance use and behavioral problems in adolescence. Sleep Med 2009, 10:787-796.
60. Coffey S.F., Dansky B.S., Carrigan M.H., Brady K.T. Acute and protracted cocaine abstinence in an outpatient population: a prospective study of mood, sleep and withdrawal symptoms. Drug Alcohol Depend 2000, 59:277-286.
61. Krystal A.D., Thakur M., Roth T. Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. Ann Clin Psychiatry 2008, 20:39-46.
62. Schierenbeck T., Riemann D., Berger M., Hornyak M. Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. Sleep Med Rev 2008, 12:381-389.
63. Jacobus J., Bava S., Cohen-Zion M., Mahmood O., Tapert S.F. Functional consequences of marijuana use in adolescents. Pharmacol Biochem Behav 2009, 92:559-565.
64. Valladares E.M., Irwin M.R. Polysomnographic sleep dysregulation in cocaine dependence. ScientificWorldJournal 2007, 7:213-216.
65. Morgan P.T., Malison R.T. Cocaine and sleep: early abstinence. ScientificWorldJournal 2007, 7:223-230.
66. Colrain I.M., Trinder J., Swan G.E. The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations. Nicotine Tob Res 2004, 6:913-925.
67. Wang D., Teichtahl H. Opioids, sleep architecture and sleep-disordered breathing. Sleep Med Rev 2007, 11:35-46.
68. McCann U.D., Ricaurte G.A. Effects of (±) 3,4-methylenedioxymethamphetamine (MDMA) on sleep and circadian rhythms. ScientificWorldJournal 2007, 7:231-238.
69. Leggio L., Ferrulli A., Malandrino N., et al. Insulin but not insulin growth factor-1 correlates with craving in currently drinking alcohol-dependent patients. Alcohol Clin Exp Res 2008, 32:450-458.
70. Leggio L., Ferrulli A., Cardone S., et al. Relationship between the hypothalamic-pituitary-thyroid axis and alcohol craving in alcohol-dependent patients: a longitudinal study. Alcohol Clin Exp Res 2008, 32:2047-2053.
71. Leggio L., Ferrulli A., Cardone S., et al. Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study. Alcohol 2008, 42:375-381.
72. Sinha R., Fox H.C., Hong K.A., Bergquist K., Bhagwagar Z., Siedlarz K.M. Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 2009, 34:1198-1208.
73. Means M.K., Edinger J.D., Glenn D.M., Fins A.I. Accuracy of sleep perceptions among insomnia sufferers and normal sleepers. Sleep Med 2003, 4:285-296.
74. Currie S.R., Malhotra S., Clark S. Agreement among subjective, objective, and collateral measures of insomnia in postwithdrawal recovering alcoholics. Behav Sleep Med 2004, 2:148-161.
75. Voss U., Holzmann R., Tuin I., Hobson J.A. Lucid dreaming: a state of consciousness with features of both waking and non-lucid dreaming. Sleep 2009, 32:1191-1200.
76. U.S. National Library of Medicine, and National Institutes of Health. PubMed Home Page. Search of Journals Database containing the word " Sleep" Available at: [accessed 09/23/2009]. http://www.ncbi.nlm.nih.gov/pubmed/.
77. Desseilles M., Dang-Vu T., Schabus M., Sterpenich V., Maquet P., Schwartz S. Neuroimaging insights into the pathophysiology of sleep disorders. Sleep 2008, 31:777-794.
78. Steiger A. Neurochemical regulation of sleep. J Psychiatr Res 2007, 41(7):537-552.
79. Altena E., Van Der Werf Y.D., Sanz-Arigita E.J., et al. Prefrontal hypoactivation and recovery in insomnia. Sleep 2008, 31:1271-1276.
80. Dauvilliers Y., Tafti M. The genetic basis of sleep disorders. Curr Pharm Des 2008, 14:3386-3395.
81. Volkow N.D., Wang G.J., Telang F., et al. Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain. J Neurosci 2008, 28:8454-8461.
82. Perreau-Lenz S., Zghoul T., Spanagel R. Clock genes running amok. Clock genes and their role in drug addiction and depression. EMBO Rep 2007, 8:S20-S23. [Spec No].
83. Bolla K.I., Lesage S.R., Gamaldo C.E., et al. Sleep disturbance in heavy marijuana users. Sleep 2008, 31:901-908.
84. Killgore W.D., Kahn-Greene E.T., Grugle N.L., Killgore D.B., Balkin T.J. Sustaining executive functions during sleep deprivation: a comparison of caffeine, dextroamphetamine, and modafinil. Sleep 2009, 32:205-216.
85. Perez A.Y., Kirkpatrick M.G., Gunderson E.W., et al. Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend 2008, 94:258-262.
86. Kirilly E., Molnar E., Balogh B., et al. Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180days. Int J Neuropsychopharmacol 2008, 11:795-809.
87. Zhang L., Samet J., Caffo B., Bankman I., Punjabi N.M. Power spectral analysis of EEG activity during sleep in cigarette smokers. Chest 2008, 133:427-432.
88. Peles E., Schreiber S., Adelson M. Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose. Eur Neuropsychopharmacol 2009, 19:581-588.
89. Sharkey K.M., Kurth M.E., Corso R.P., Brower K.J., Millman R.P., Stein M.D. Home polysomnography in methadone maintenance patients with subjective sleep complaints. Am J Drug Alcohol Abuse 2009, 35:178-182.
90. Irwin M.R., Olmstead R., Valladares E.M., Breen E.C., Ehlers C.L. Tumor necrosis factor antagonism normalizes rapid eye movement sleep in alcohol dependence. Biol Psychiatry 2009, 66:191-195.
91. Colrain I.M., Crowley K.E., Nicholas C.L., Padilla M., Baker F.C. The impact of alcoholism on sleep evoked delta frequency responses. Biol Psychiatry 2009, 66:177-184.
92. Chueh K.H., Yang M.S., Chen C.S., Chiou S.M. Poor sleep quality and alcohol use problems among elderly Taiwanese aboriginal women. Int Psychogeriatr 2009, 21:593-599.
93. Schmidt R.E., Gay P., Van der Linden M. Facets of impulsivity are differentially linked to insomnia: evidence from an exploratory study. Behav Sleep Med 2008, 6:178-192.
94. Muller S.E., Weijers H.G., Boning J., Wiesbeck G.A. Personality traits predict treatment outcome in alcohol-dependent patients. Neuropsychobiology 2008, 57:159-164.
95. Friedmann P.D., Rose J.S., Swift R., Stout R.L., Millman R.P., Stein M.D. Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial. Alcohol Clin Exp Res 2008, 32:1652-1660.